We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Accelerating Proteome Analysis With PASEF: A Unique and Sensitive Technique
Accelerating Proteome Analysis With PASEF: A Unique and Sensitive Technique
Blog

Understanding the proteome is a fundamental challenge of biology. Here, Bruker Daltonics' Gary Kruppa and Scarlet Koch outline a new method, Parallel Accumulation Serial Fragmentation (PASEF) that offers faster, more sensitive and more robust proteome analysis, giving scientists the potential to discover low-level, biologically significant proteins and validate them in research.

Read More

Raising the Standards of Data Integrity in Modern Research
Raising the Standards of Data Integrity in Modern Research
Blog

As the research landscape changes, the standards of data integrity that guide research must also change. New data tools, systems and formats provide pitfalls and opportunities for advancing the cause of data integrity. In this blog, we discuss integrity in modern research with John Sadler, Vice President and General Manager of Agilent’s Software & Informatics Division.

Read More

Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment
Genomic Profiling in Cancer: Matching Patients to Precision Trials, Guiding Patients to the Right Treatment
Blog

We recently spoke to Gaurav Singal, Vice President of Data Strategy and Product Development at Foundation Medicine, to learn more about how their SmartTrialsTM technology platform has enabled patients to be rapidly matched to precision trials, based on their unique tumor biomarkers.

Read More

Providing Peace of Mind: Ultra Low-Level Detection of Pesticides in Baby Food
Providing Peace of Mind: Ultra Low-Level Detection of Pesticides in Baby Food
Blog

Pesticides are widely used to protect food crops from damage and consequently have the potential to end up in the food we eat. Young children and babies can be particularly susceptible to pesticide residues in food so testing for pesticide residues in food, and baby food in particular, is therefore critical for the preservation of human health.

Read More

Accelerating the Development of Organs-on-Chips
Accelerating the Development of Organs-on-Chips
Blog

Emulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.

Read More

AI and Humans: Working Together to Improve Diagnosis
AI and Humans: Working Together to Improve Diagnosis
Blog

To learn more about the impact AI has already had on diagnostics and health services, as well as some of its future capabilities, we spoke to Chris Scarisbrick.

Read More

Novel Neuromuscular Junction Model Benefits Drug Discovery
Novel Neuromuscular Junction Model Benefits Drug Discovery
Blog

The first functional stem-cell derived neuromuscular junction model has recently been licensed, which could help the quest to develop new drugs to treat associated neurodegenerative diseases. We caught up with James Hickman, CSO, Hesperos, to learn more about the model, and some of the benefits it brings.

Read More

Bringing Behavioral Assays to the Bench
Bringing Behavioral Assays to the Bench
Blog

How do you reliably quantify behavior? Zantiks CEO Dr. Bill Budenberg Explains

Read More

Harnessing Stem Cells for Blood Vessel Regeneration
Harnessing Stem Cells for Blood Vessel Regeneration
Blog

Vascugen recently announced that it had licensed stem cell technology for blood vessel regeneration at IU School of Medicine, which could lead to new treatment options for patients suffering from Peripheral Artery Disease and Critical Limb Ischemia. We caught up with Carter Cliff, CEO, Vascugen to learn more about the technology and the science behind it.

Read More

Flow Technology Innovations Driving Drug Discovery Forward
Flow Technology Innovations Driving Drug Discovery Forward
Blog

Flow chemistry is playing an increasingly prominent role in drug discovery, enabling those in the field to streamline chemistry discovery and development efforts. Finding ways to reduce the time it takes to generate validated small-molecule compounds would be highly advantageous – which is exactly why scientists at Abbvie developed SWIFT.

Read More